Goldman Sachs Starts TiVo (TIVO) at Buy, Pieces Falling Into Place
Get Alerts TIVO Hot Sheet
Price: $6.09 --0%
Rating Summary:
10 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
10 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Goldman Sachs initiates coverage on TiVo (NASDAQ: TIVO) with a Buy and $15 price target, saying pieces are falling into place.
The firm comments, ". We view TiVo as a leading vendor well positioned to target consumers who desire a premium viewing experience in the digital living room and on mobile devices. With the pieces of the profitability puzzle falling into place (improving churn for its TiVo-owned subscribers, a positive inflection for its MSO subscriber base ex-Virgin Media, continued traction with Virgin Media, and recently signed distribution deals), along with R&D cost controls, we see a reasonable foundation for management’s adjusted EBITDA profitability goal for FY14 and beyond."
For an analyst ratings summary and ratings history on TiVo click here. For more ratings news on TiVo click here.
Shares of TiVo closed at $12.43 yesterday.
The firm comments, ". We view TiVo as a leading vendor well positioned to target consumers who desire a premium viewing experience in the digital living room and on mobile devices. With the pieces of the profitability puzzle falling into place (improving churn for its TiVo-owned subscribers, a positive inflection for its MSO subscriber base ex-Virgin Media, continued traction with Virgin Media, and recently signed distribution deals), along with R&D cost controls, we see a reasonable foundation for management’s adjusted EBITDA profitability goal for FY14 and beyond."
For an analyst ratings summary and ratings history on TiVo click here. For more ratings news on TiVo click here.
Shares of TiVo closed at $12.43 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
- BMO Capital Starts Energy Fuels (UUUU) at Outperform
- Leerink Starts Ligand Pharma (LGND) at Outperform
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share